PP Piccaluga, M Malagola, M Amabile, M Rondoni, S Paolini, F Pane, D Russo, G Visani, M Baccarani, G Martinelli. The achievement of molecular complete remission during treatment with imatinib mesylate correlates with relapse-free survival in bcr/abl-positive acute lymphoid leukemia patients. haematol [Internet]. 2004Oct.1 [cited 2024Nov.24];89(10):1269-71. Available from: https://haematologica.org/article/view/3264